α-synuclein aggregation and neurodegenerative diseases

Journal of Alzheimer's Disease

Volumn 5, Issue 2, 2003, Pages 139-148

  Ma, Qiu Lan ^a,b   Chan, Piu ^b   Yoshii, Mitsunobu ^a   Uéda, Kenji ^a,b  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; COMPLEMENTARY DNA;

ALZHEIMER DISEASE; AMINO ACID SUBSTITUTION; AUTOSOMAL DOMINANT DISORDER; CELL INCLUSION; DEGENERATIVE DISEASE; HUMAN; LEWY BODY; MISSENSE MUTATION; MOLECULAR CLONING; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN AGGREGATION; REVIEW; SENILE PLAQUE; SHY DRAGER SYNDROME;

EID: 0037954360     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2003-5208     Document Type: Review

References (104)

1. A. Abeliovich, Y. Schmitz, I. Farinas, D. Choi-Lundberg, W.H. Ho, P.E. Castillo, N. Shinsky, J.M. Verdugo, M. Armanini, A. Ryan, M. Hynes, H. Phillips, D. Sulzer and A. Rosenthal, Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system, Neuron 25 (2000), 239-252.
2. A.N. Akopian and J.N. Wood, Peripheral nervous system-specific genes identified by subtractive cDNA cloning, J Biol Chem 270 (1995), 21264-21270.
3. M.A. Alim, M.S. Hossain, K. Arima, K. Takeda, Y. Izumiyama, M. Nakamura, H. Kaji, T. Shinoda, S. Hisanaga and K. Uéda, Tubulin seeds alpha-synuclein fibril formation, J Biol Chem 277 (2002), 2112-2117.
4. K. Arima, S. Hirai, N. Sunohara, K. Aoto, Y. Izumiyama, K. Uéda, K. Ikeda and M. Kawai, Cellular co-localization of phosphorylated tau- and NACP/alpha-synuclein-epitopes in lewy bodies in sporadic Parkinson's disease and in dementia with Lewy bodies, Brain Res 843 (1999), 53-61.
5. K. Arima, K. Uéda, N. Sunohara, K. Arakawa, S. Hirai, M. Nakamura, H. Tonozuka-Uehara and M. Kawai, NACP/alpha-synuclein immunoreactivity in fibrillary components of neuronal and oligodendroglial cytoplasmic inclusions in the pontine nuclei in multiple system atrophy, Acta Neuropathol (Berl) 96 (1998), 439-444.
6. K. Arima, K. Uéda, N. Sunohara, S. Hirai, Y. Izumiyama, H. Tonozuka-Uehara and M. Kawai, Immunoelectronmicroscopic demonstration of NACP/alpha-synucleinepitopes on the filamentous component of Lewy bodies in Parkinson's disease and in dementia with Lewy bodies, Brain Res 808 (1998), 93-100.
7. M. Baba, S. Nakajo, P.H. Tu, T. Tomita, K. Nakaya, V.M. Lee, J.Q. Trojanowski and T. Iwatsubo, Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson's disease and dementia with Lewy bodies, Am J Pathol 152 (1998), 879-884.
8. V.L. Buchman, H.J. Hunter, L.G. Pinon, J. Thompson, E.M. Privalova, N.N. Ninkina and A.M. Davies, Persyn, a member of the synuclein family, has a distinct pattern of expression in the developing nervous system, J Neurosci 18 (1998), 9335-9341.
9. D. Campion, C. Martin, R. Heilig, F. Charbonnier, V. Moreau, J.M. Flaman, J.L. Petit, D. Hannequin, A. Brice and T. Frebourg, The NACP/synuclein gene: chromosomal assignment and screening for alterations in Alzheimer disease, Genomics 26 (1995), 254-257.
10. X. Chen, H.A. de Silva, M.J. Pettenati, P.N. Rao, P. St George-Hyslop, A.D. Roses, Y. Xia, K. Horsburgh, K. Uéda and T. Saitoh, The human NACP/alpha-synuclein gene: chromosome assignment to 4q21.3-q22 and TaqI RFLP analysis, Genomics 26 (1995), 425-427.
11. O. Chiba-Falek and R.L. Nussbaum, Effect of allelic variation at the NACP-Rep1 repeat upstream of the alpha-synuclein gene (SNCA) on transcription in a cell culture luciferase reporter system, Hum Mol Genet 10 (2001), 3101-3109.
12. D.F. Clayton and J.M. George, Synucleins in synaptic plasticity and neurodegenerative disorders, J Neurosci Res 58 (1999), 120-129.
13. D.F. Clayton and J.M. George, The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease, Trends Neurosci 21 (1998), 249-254.
14. K.A. Conway, J.D. Harper and P.T. Lansbury, Accelerated in vitro fibril formation by a mutant alpha-synuclein linked to early-onset Parkinson disease, Nat Med 4 (1998), 1318-1320.
15. K.A. Conway, S.J. Lee, J.C. Rochet, T.T. Ding, R.E. Williamson and P.T. Lansbury, Jr., Acceleration of oligomerization, not fibrillization, is a shared property of both alpha-synuclein mutations linked to early-onset Parkinson's disease: implications for pathogenesis and therapy, Proc Natl Acad Sci USA 97 (2000), 571-576.
16. O.M. El-Agnaf, R. Jakes, M.D. Curran and A. Wallace, Effects of the mutations Ala30 to Pro and Ala53 to Thr on the physical and morphological properties of alpha-synuclein protein implicated in Parkinson's disease, FEBS Lett 440 (1998), 67-70.
17. S. Engelender, Z. Kaminsky, X. Guo, A.H. Sharp, R.K. Amaravi, J.J. Kleiderlein, R.L. Margolis, J.C. Troncoso, A.A. Lanahan, P.F. Worley, V.L. Dawson, T.M. Dawson and C.A. Ross, Synphilin-1 associates with alpha-synuclein and promotes the formation of cytosolic inclusions, Nat Genet 22 (1999), 110-114.
18. M. Farrer, D.M. Maraganore, P. Lockhart, A. Singleton, T.G. Lesnick, M. de Andrade, A. West, R. de Silva, J. Hardy and D. Hernandez, alpha-Synuclein gene haplotypes are associated with Parkinson's disease, Hum Mol Genet 10 (2001), 1847-1851.
19. M.B. Feany and W.W. Bender, A Drosophila model of Parkinson's disease, Nature 404 (2000), 394-398.
20. M.S. Forman, M.L. Schmidt, S. Kasturi, D.P. Perl, V.M. Lee and J.Q. Trojanowski, Tau and alpha-synuclein pathology in amygdala of Parkinsonism-dementia complex patients of Guam, Am J Pathol 160 (2002), 1725-1731.
21. J.E. Galvin, V.M. Lee and J.Q. Trojanowski, Synucleinopathies: clinical and pathological implications, Arch Neurol 58 (2001), 186-190.
22. J.M. George, The synucleins, Genome Biol 3 (2002), REVIEWS3002.
23. J.M. George, H. Jin, W.S. Woods and D.F. Clayton, Characterization of a novel protein regulated during the critical period for song learning in the zebra finch, Neuron 15 (1995), 361-372.
24. B.I. Giasson, J.E. Duda, I.V. Murray, Q. Chen, J.M. Souza, H.I. Hurtig, H. Ischiropoulos, J.Q. Trojanowski and V.M. Lee, Oxidative damage linked to neurodegeneration by selective alpha-synuclein nitration in synucleinopathy lesions, Science 290 (2000), 985-989.
25. B.I. Giasson, K. Uryu, J.Q. Trojanowski and V.M. Lee, Mutant and wild type human alpha-synucleins assemble into elongated filaments with distinct morphologies in vitro, J Biol Chem 274 (1999), 7619-7622.
26. T. Gomez-Isla, M.C. Irizarry, A. Mariash, B. Cheung, O. Soto, S. Schrump, J. Sondel, L. Kotilinek, J. Day, M. A. Schwarzschild, J.J. Cha, K. Newell, D. Miller, K. Uéda, A.B. Young, B.T. Hyman and K.H. Ashe, Motor dysfunction and gliosis with preserved dopaminergic markers in human alpha-synuclein A30P transgenic mice, Neurobiol Aging 24 (2003), 245-258.
27. S. Haik, N. Privat, K.T. Adjou, V. Sazdovitch, D. Dormont, C. Duyckaerts and J.J. Hauw, Alpha-synuclein-immunoreactive deposits in human and animal prion diseases, Acta Neuropathol (Berl) 103 (2002), 516-520.
28. M. Hashimoto, L.J. Hsu, A. Sisk, Y. Xia, A. Takeda and M. Sundsmo, E. Masliah, Human recombinant NACP/alpha-synuclein is aggregated and fibrillated in vitro: relevance for Lewy body disease, Brain Res 799 (1998), 301-306.
29. M. Hashimoto, L.J. Hsu, Y. Xia, A. Takeda, A. Sisk, M. Sundsmo and E. Masliah, Oxidative stress induces amyloid-like aggregate formation of NACP/alpha-synuclein in vitro, Neuroreport 10 (1999), 717-721.
30. M. Hashimoto, T. Takenouchi, M. Mallory, E. Masliah and A. Takeda, The role of NAC in amyloidogenesis in Alzheimer's disease, Am J Pathol 156 (2000), 734-736.
31. M. Hashimoto, M. Yoshimoto, A. Sisk, L.J. Hsu, M. Sundsmo, A. Kittel, T. Saitoh, A. Miller and E. Masliah, NACP, a synaptic protein involved in Alzheimer's disease, is differentially regulated during megakaryocyte differentiation, Biochem Biophys Res Commun 237 (1997), 611-616.
32. N.E. Hellman, E.A. Grant and A.M. Goate, Failure to replicate a protective effect of allele 2 of NACP/alpha-synuclein polymorphism in Alzheimer's disease: an association study, Ann Neurol 44 (1998), 278-281.
33. L.J. Hsu, M. Mallory, Y. Xia, I. Veinbergs, M. Hashimoto, M. Yoshimoto, L.J. Thal, T. Saitoh and E. Masliah, Expression pattern of synucleins (non-Abeta component of Alzheimer's disease amyloid precursor protein/alpha-synuclein) during murine brain development, J Neurochem 71 (1998), 338-344.
34. M.C. Irizarry, T.W. Kim, M. McNamara, R.E. Tanzi, J.M. George, D.F. Clayton and B.T. Hyman, Characterization of the precursor protein of the non-A beta component of senile plaques (NACP) in the human central nervous system, J Neuropathol Exp Neurol 55 (1996), 889-895.
35. E. Iseki, N. Takayama, Y. Furukawa, W. Marui, T. Nakai, S. Miura, K. Uéda and K. Kosaka, Immunohistochemical study of synphilin-1 in brains of patients with dementia with Lewy bodies - synphilin-1 is non-specifically implicated in the formation of different neuronal cytoskeletal inclusions, Neurosci Lett 326 (2002), 211-215.
36. A. Iwai, E. Masliah, M. Yoshimoto, N. Ge, L. Flanagan, H.A. de Silva, A. Kittel and T. Saitoh, The precursor protein of non-A beta component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system, Neuron 14 (1995), 467-475.
37. A. Iwata, S. Miura, I. Kanazawa, M. Sawada, N. Nukina, alpha-Synuclein forms a complex with transcription factor Elk-1, J Neurochem 77 (2001), 239-252.
38. Y. Izumi, H. Morino, M. Oda, H. Maruyama, F. Udaka, M. Kameyama, S. Nakamura and H. Kawakami, Genetic studies in Parkinson's disease with an alpha-synuclein/NACP gene polymorphism in Japan, Neurosci Lett 300 (2001), 125-127.
39. R. Jakes, M.G. Spillantini and M. Goedert, Identification of two distinct synucleins from human brain, FEBS Lett 345 (1994), 27-32.
40. J.M. Jenco, A. Rawlingson, B. Daniels and A.J. Morris, Regulation of phospholipase D2: selective inhibition of mammalian phospholipase D isoenzymes by alpha- and beta-synucleins, Biochemistry 37 (1998), 4901-4909.
41. P.H. Jensen, H. Hager, M.S. Nielsen, P. Hojrup, J. Gliemann and R. Jakes, alpha-synuclein binds to Tau and stimulates the protein kinase A-catalyzed tau phosphorylation of serine residues 262 and 356, J Biol Chem 274 (1999), 25481-25489.
42. P.H. Jensen, M.S. Nielsen, R. Jakes, C.G. Dotti and M. Goedert, Binding of alpha-synuclein to brain vesicles is abolished by familial Parkinson's disease mutation, J Biol Chem 273 (1998), 26292-26294.
43. E. Jo, J. McLaurin, C.M. Yip, P. St George-Hyslop and P.E. Fraser, alpha-Synuclein membrane interactions and lipid specificity, J Biol Chem 275 (2000), 34328-34334.
44. E. Junn and M.M. Mouradian, Human alpha-synuclein over-expression increases intracellular reactive oxygen species levels and susceptibility to dopamine, Neurosci Lett 320 (2002), 146-150.
45. P.J. Kahle, M. Neumann, L. Ozmen, V. Muller, H. Jacobsen, A. Schindzielorz, M. Okochi, U. Leimer, H. van Der Putten, A. Probst, E. Kremmer, H.A. Kretzschmar and C. Haass, Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha -synuclein in human and transgenic mouse brain, J Neurosci 20 (2000), 6365-6373.
46. P.J. Kahle, M. Neumann, L. Ozmen, V. Muller, H. Jacobsen, W. Spooren, B. Fuss, B. Mallon, W.B. Macklin, H. Fujiwara, M. Hasegawa, T. Iwatsubo, H.A. Kretzschmar and C. Haass, Hyperphosphorylation and insolubility of alpha-synuclein in transgenic mouse oligodendrocytes, EMBO Rep 3 (2002), 583-588.
47. S. Kanda, J.F. Bishop, M.A. Eglitis, Y. Yang and M.M. Mouradian, Enhanced vulnerability to oxidative stress by alpha-synuclein mutations and C-terminal truncation, Neuroscience 97 (2000), 279-284.
48. H. Kaufmann, K. Hague and D. Perl, Accumulation of alpha-synuclein in autonomic nerves in pure autonomic failure, Neurology 56 (2001), 980-981.
49. J. Kim, Evidence that the precursor protein of non-A beta component of Alzheimer's disease amyloid (NACP) has an extended structure primarily composed of random-coil, Mol Cells 7 (1997), 78-83.
50. T.D. Kim, S.R. Paik, C.H. Yang and J. Kim, Structural changes in alpha-synuclein affect its chaperone-like activity in vitro, Protein Sci 9 (2000), 2489-2496.
51. R. Krüger, W. Kuhn, T. Muller, D. Woitalla, M. Graeber, S. Kosel, H. Przuntek, J.T. Epplen, L. Schols and O. Riess, Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease, Nat Genet 18 (1998), 106-108.
52. R. Krüger, A.M. Vieira-Saecker, W. Kuhn, D. Berg, T. Muller, N. Kuhnl, G.A. Fuchs, A. Storch, M. Hungs, D. Woitalla, H. Przuntek, J.T. Epplen, L. Schols and O. Riess, Increased susceptibility to sporadic Parkinson's disease by a certain combined alpha-synuclein/apolipoprotein E genotype, Ann Neurol 45 (1999), 611-617.
53. C. Lavedan, E. Leroy, A. Dehejia. S. Buchholtz, A. Dutra, R.L. Nussbaum and M.H. Polymeropoulos, Identification, localization and characterization of the human gamma-synuclein gene, Hum Genet 103 (1998), 106-112.
54. D. Lee, E.K. Lee, J.H. Lee, C.S. Chang and S.R. Paik, Self-oligomerization and protein aggregation of alpha-synuclein in the presence of Coomassie Brilliant Blue, Eur J Biochem 268 (2001), 295-301.
55. M. Lee, D. Hyun, B. Halliwell and P. Jenner, Effect of the overexpression of wild-type or mutant alpha-synuclein on cell susceptibility to insult, J Neurochem 76 (2001), 998-1009.
56. J.Y. Li, P. Henning Jensen and A. Dahlstrom, Differential localization of alpha-, beta- and gamma-synucleins in the rat CNS, Neuroscience 113 (2002), 463-478.
57. C.D. Link, Transgenic invertebrate models of age-associated neurodegenerative diseases, Mech Ageing Dev 122 (2001), 1639-1649.
58. C.F. Lippa, M.L. Schmidt, V.M. Lee and J.Q. Trojanowski, Antibodies to alpha-synuclein detect Lewy bodies in many Down's syndrome brains with Alzheimer's disease, Ann Neurol 45 (1999), 353-357.
59. L. Maroteaux, J.T. Campanelli and R.H. Scheller, Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal, J Neurosci 8 (1988), 2804-2815.
60. L. Maroteaux and R.H. Scheller, The rat brain synucleins; family of proteins transiently associated with neuronal membrane, Brain Res Mol Brain Res 11 (1991), 335-343.
61. W. Marui, E. Iseki, K. Uéda and K. Kosaka, Occurrence of human alpha-synuclein immunoreactive neurons with neurofibrillary tangle formation in the limbic areas of patients with Alzheimer's disease, J Neurol Sci 174 (2000), 81-84.
62. E. Masliah, A. Iwai, M. Mallory, K. Uéda and T. Saitoh, Altered presynaptic protein NACP is associated with plaque formation and neurodegeneration in Alzheimer's disease, Am J Pathol 148 (1996), 201-210.
63. E. Masliah, E. Rockenstein, I. Veinbergs, M. Mallory, M. Hashimoto, A. Takeda, Y. Sagara, A. Sisk and L. Mucke, Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders, Science 287 (2000), 1265-1269.
64. P.J. McLean, H. Kawamata, S. Ribich and B.T. Hyman, Membrane association and protein conformation of alpha-synuclein in intact neurons, Effect of Parkinson's disease-linked mutations, J Biol Chem 275 (2000), 8812-8816.
65. F. Mori, C. Inenaga, M. Yoshimoto, H. Umezu, R. Tanaka, H. Takahashi and K. Wakabayashi, Alpha-synuclein immunoreactivity in normal and neoplastic Schwann cells, Acta Neuropathol (Berl) 103 (2002), 145-151.
66. D.D. Murphy, S.M. Rueter, J.Q. Trojanowski and V.M. Lee, Synucleins are developmentally expressed, and alpha-synuclein regulates the size of the presynaptic vesicular pool in primary hippocampal neurons, J Neurosci 20 (2000), 3214-3220.
67. S. Nakajo, K. Tsukada, K. Omata, Y. Nakamura and K. Nakaya, A new brain-specific 14-kDa protein is a phosphoprotein, Its complete amino acid sequence and evidence for phosphorylation, Eur J Biochem 217 (1993), 1057-1063.
68. K. Nakano, J. Chen, G.E. Tarr, T. Yoshida, J.M. Flynn and M.W. Bitensky, Rethinking the role of phosducin: light-regulated binding of phosducin to 14-3-3 in rod inner segments, Proc Natl Acad Sci USA 98 (2001), 4693-4698.
69. L. Narhi, S.J. Wood, S. Steavenson, Y. Jiang, G.M. Wu, D. Anafi, S.A. Kaufman, F. Martin, K. Sitney, P. Denis, J.C. Louis, J. Wypych, A.L. Biere and M. Citron, Both familial Parkinson's disease mutations accelerate alpha-synuclein aggregation, J Biol Chem 274 (1999), 9843-9846.
70. N. Ostrerova, L. Petrucelli, M. Farrer, N. Mehta, P. Choi, J. Hardy and B. Wolozin, alpha-Synuclein shares physical and functional homology with 14-3-3 proteins, J Neurosci 19 (1999), 5782-5791.
71. N. Ostrerova-Golts, L. Petrucelli, J. Hardy, J.M. Lee, M. Farer and B. Wolozin, The A53T alpha-synuclein mutation increases iron-dependent aggregation and toxicity, J Neurosci 20 (2000), 6048-6054.
72. S.R. Paik, J.H. Lee, D.H. Kim, C.S. Chang and Y.S. Kim, Self-oligomerization of NACP, the precursor protein of the non-amyloid beta/A4 protein (A beta) component of Alzheimer's disease amyloid, observed in the presence of a C-terminal A beta fragment (residues 25-35), FEBS Lett 421 (1998), 73-76.
73. S.R. Paik, H.J. Shin, J.H. Lee, C.S. Chang and J. Kim, Copper(II)-induced self-oligomerization of alpha-synuclein, Biochem J 340(Pt 3) (1999), 821-828.
74. K. Petersen, O.F. Olesen and J.D. Mikkelsen, Developmental expression of alpha-synuclein in rat hippocampus and cerebral cortex, Neuroscience 91 (1999), 651-659.
75. M.H. Polymeropoulos, C. Lavedan, E. Leroy, S.E. Ide, A. Dehejia, A. Dutra, B. Pike, H. Root, J. Rubenstein, R. Boyer, E.S. Stenroos, S. Chandrasekharappa, A. Athanassiadou, T. Papapetropoulos, W.G. Johnson, A.M. Lazzarini, R.C. Duvoisin, G. Di Iorio, L.I. Golbe and R.L. Nussbaum, Mutation in the alpha-synuclein gene identified in families with Parkinson's disease, Science 276 (1997), 2045-2047.
76. C. Richter-Landsberg, M. Gorath, J.Q. Trojanowski and V.M. Lee, alpha-synuclein is developmentally expressed in cultured rat brain oligodendrocytes, J Neurosci Res 62 (2000), 9-14.
77. R. Sharon, M.S. Goldberg, I. Bar-Josef, R.A. Betensky, J. Shen and D.J. Selkoe, alpha-Synuclein occurs in lipid-rich high molecular weight complexes, binds fatty acids, and shows homology to the fatty acid-binding proteins, Proc Natl Acad Sci USA 98 (2001), 9110-9115.
78. Y. Shibasaki, D.A. Baillie, D. St Clair and A.J. Brookes, High-resolution mapping of SNCA encoding alpha-synuclein, the non-A beta component of Alzheimer's disease amyloid precursor, to human chromosome 4q21.3-
79. T. Shibayama-Imazu, I. Okahashi, K. Omata, S. Nakajo, H. Ochiai, Y. Nakai, T. Hama, Y. Nakamura and K. Nakaya, Cell and tissue distribution and developmental change of neuron specific 14 kDa protein (phosphoneuroprotein 14), Brain Res 622 (1993), 17-25.
80. E.C. Shin, S.E. Cho, D.K. Lee, M.W. Hur, S.R. Paik, J.H. Park and J. Kim, Expression patterns of alpha-synuclein in human hematopoietic cells and in Drosophila at different developmental stages, Mol Cells 10 (2000), 65-70.
81. H.J. Shin, E.K. Lee, J.H. Lee, D. Lee, C.S. Chang, Y.S. Kim and S.R. Paik, Eosin interaction of alpha-synuclein leading to protein self-oligomerization, Biochim Biophys Acta 1481 (2000), 139-146.
82. M. Shoji, Y. Harigaya, A. Sasaki, K. Ueda, K. Ishiguro, E. Matsubara, M. Watanabe, M. Ikeda, M. Kanai, Y. Tomidokoro, M. Shizuka, M. Amari, K. Kosaka, Y. Nakazato, K. Okamoto and S. Hirai, Accumulation of NACP/alpha-synuclein in lewy body disease and multiple system atrophy, J Neurol Neurosurg Psychiatry 68 (2000), 605-608.
83. B. Sommer, S. Barbieri, K. Hofele, K. Wiederhold, A. Probst, C. Mistl, S. Danner, S. Kauffmann, W. Spooren, M. Tolnay, G. Bilbe, H. van der Putten, S. Kafmann, P. Caromi and M.A. Ruegg, Mouse models of alpha-synucleinopathy and Lewy pathology, Exp Gerontol 35 (2000), 1389-1403.
84. M.G. Spillantini, R.A. Crowther, R. Jakes, M. Hasegawa and M. Goedert, alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies, Proc Natl Acad Sci USA 95 (1998), 6469-6473.
85. L. Stefanis, K.E. Larsen, H.J. Rideout, D. Sulzer and L.A. Greene, Expression of A53T mutant but not wild-type alpha-synuclein in PC12 cells induces alterations of the ubiquitin-dependent degradation system, loss of dopamine release, and autophagic cell death, J Neurosci 21 (2001), 9549-9560.
86. N. Stefanova, M. Emgard, L. Klimaschewski, G.K. Wenning and M. Reindl, Ultrastructure of alpha-synuclein-positive aggregations in U373 astrocytoma and rat primary glial cells, Neurosci Lett 323 (2002), 37-40.
87. A. Surguchov, I. Surgucheva, E. Solessio and W. Baehr, Synoretin-A new protein belonging to the synuclein family, Mol Cell Neurosci 13 (1999), 95-103.
88. A. Takeda, M. Hashimoto, M. Mallory, M. Sundsumo, L. Hansen and E. Masliah, C-terminal alpha-synuclein immunoreactivity in structures other than Lewy bodies in neurodegenerative disorders, Acta Neuropathol (Berl) 99 (2000), 296-304.
89. E.K. Tan, T. Matsuura, S. Nagamitsu, M. Khajavi, J. Jankovic and T. Ashizawa, Polymorphism of NACP-Rep1 in Parkinson's disease: an etiologic link with essential tremor? Neurology 54 (2000), 1195-1198.
90. K. Tanji, T. Imaizumi, H. Yoshida, F. Mori, M. Yoshimoto, K. Satoh and K. Wakabayashi, Expression of alpha-synuclein in a human glioma cell line and its up-regulation by interleukin-1beta, Neuroreport 12 (2001), 1909-1912.
91. J.W. Touchman, A. Dehejia, O. Chiba-Falek, D.E. Cabin, J.R. Schwartz, B.M. Orrison, M.H. Polymeropoulos and R.L. Nussbaum, Human and mouse alpha-synuclein genes: comparative genomic sequence analysis and identification of a novel gene regulatory element, Genome Res 11 (2001), 78-86.
92. K. Uéda, H. Fukushima, E. Masliah, Y. Xia, A. Iwai, M. Yoshimoto, D.A. Otero, J. Kondo, Y. Ihara and T. Saitoh, Molecular cloning of cDNA encoding an unrecognized component of amyloid in Alzheimer disease, Proc Natl Acad Sci USA 90 (1993), 11282-11286.
93. K. Uéda, T. Saitoh and H. Mori, Tissue-dependent alternative splicing of mRNA for NACP, the precursor of non-A beta component of Alzheimer's disease amyloid, Biochem Biophys Res Commun 205 (1994), 1366-1372.
94. H. van der Putten, K.H. Wiederhold, A. Probst, S. Barbieri, C. Mistl, S. Danner, S. Kauffmann, K. Hofele, W.P. Spooren, M.A. Ruegg, S. Lin, P. Caroni, B. Sommer, M. Tolnay and G. Bilbe, Neuropathology in mice expressing human alpha-synuclein, J Neurosci 20 (2000), 6021-6029.
95. K. Wakabayashi, S. Engelender, M. Yoshimoto, S. Tsuji, C.A. Ross and H. Takahashi, Synphilin-1 is present in Lewy bodies in Parkinson's disease, Ann Neurol 47 (2000), 521-523.
96. K. Wakabayashi, T. Fukushima, R. Koide, Y. Horikawa, M. Hasegawa, Y. Watanabe, T. Noda, I. Eguchi, T. Morita, M. Yoshimoto, T. Iwatsubo and H. Takahashi, Juvenile-onset generalized neuroaxonal dystrophy (Hallervorden-Spatz disease) with diffuse neurofibrillary and lewy body pathology, Acta Neuropathol (Berl) 99 (2000), 331-336.
97. P.H. Weinreb, W. Zhen, A.W. Poon, K.A. Conway and P.T. Lansbury, Jr., NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded, Biochemistry 35 (1996), 13709-13715.
98. G.S. Withers, J.M. George, G.A. Banker and D.F. Clayton, Delayed localization of synelfin (synuclein, NACP) to presynaptic terminals in cultured rat hippocampal neurons, Brain Res Dev Brain Res 99 (1997), 87-94.
99. S.J. Wood, J. Wypych, S. Steavenson, J.C. Louis, M. Citron and A.L. Biere, alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease, J Biol Chem 274 (1999), 19509-19512.
100. Y. Xia, H.A. Rohan de Silva, B.L. Rosi, L.H. Yamaoka, J.B. Rimmler, M.A. Pericak-Vance, A.D. Roses, X. Chen, E. Masliah, R. DeTeresa, A. Iwai, M. Sundsmo, R.G. Thomas, C.R. Hofstetter, E. Gregory, L.A. Hansen, R. Katzman, L.J. Thal and T. Saitoh, Genetic studies in Alzheimer's disease with an NACP/alpha-synuclein polymorphism, Ann Neurol 40 (1996), 207-215.
101. Y. Xia, T. Saitoh, K. Uéda, S. Tanaka, X. Chen, M. Hashimoto, L. Hsu, C. Conrad, M. Sundsmo, M. Yoshimoto, L. Thal, R. Katzman and E. Masliah, Characterization of the human alpha-synuclein gene: Genomic structure, transcription start site, promoter region and polymorphisms, J Alzheimer's Dis 3 (2001), 485-494.
102. M. Yamazaki, Y. Arai, M. Baba, T. Iwatsubo, O. Mori, Y. Katayama and K. Oyanagi, Alpha-synuclein inclusions in amygdala in the brains of patients with the parkinsonism-dementia complex of Guam, J Neuropathol Exp Neurol 59 (2000), 585-591.
103. M. Yoshimoto, A. Iwai, D. Kang, D.A. Otero, Y. Xia and T. Saitoh, NACP, the precursor protein of the non-amyloid beta/A4 protein (A beta) component of Alzheimer disease amyloid, binds A beta and stimulates A beta aggregation, Proc Natl Acad Sci USA 92 (1995), 9141-9145.
104. W. Zhou, M.S. Hurlbert, J. Schaack, K.N. Prasad and C.R. Freed, Overexpression of human alpha-synuclein causes dopamine neuron death in rat primary culture and immortalized mesencephalon-derived cells, Brain Res 866 (2000), 33-43.